NewsStay Updated with the Latest News from 3billion.
3billion Inc.
3billion is dedicated to creating a world where patients with rare diseases are not neglected in diagnosis and treatment.
Clinical Utility of Genetic Testing for Rare Diseases
3billion is selected for oral presentation in ASHG 2023
Sequencer now upgraded to the latest sequencing technology, Illumina NovaSeq X
3billion won Xcelerate Rare challenge sponsored by Global Genes and Roche
Diagnosing Rare Mendelian Disorders in the Genomic Era
Exome is great, but Genome is better